BioCentury
ARTICLE | Company News

AZN, CytImmune in cancer deal

December 28, 2012 12:48 AM UTC

AstraZeneca plc (LSE:AZN; NYSE:AZN) partnered with CytImmune Sciences Inc. (Rockville, Md.) to evaluate the feasibility of combining an undisclosed preclinical cancer compound from the pharma with Cyt...